Abstract A 2-year-old domestic shorthair cat was presented with a history of hematuria, stranguria, and intermittent urethral obstruction. Urine sedimentation showed hematuria, pyuria, and yellow-brown, amorphous, and spherical crystals. Upon surgical correction of the obstructed urethra by perineal urethrostomy, many dark yellow to grey, irregular, gravel-like to millet grain-sized uroliths were found. These uroliths were shown to consist of 100 % xanthine by crystallography. The urinary xanthine concentration was high. The cat subsequently developed bilateral nephroliths, recurrent urinary tract infections, and chronic kidney failure. Dietary management with a low-purine diet failed in part due to poor compliance, and the cat was euthanized at 6 years of age. Xanthinuria is a rare inborn error of metabolism in cats and some other species but should be considered as a differential diagnosis in cases of feline urolithiasis. No associated molecular genetic defect has been elucidated, and management of these cases is difficult. In the absence of calculi for analysis, measuring urinary xanthine concentration can help in diagnosing this metabolic defect.
Introduction
Purines are metabolized to hypoxanthine, and the enzyme xanthine dehydrogenase (XDH) catalyzes conversion from hypoxanthine to xanthine and then from xanthine into uric acid. Hepatic uricase converts uric acid to allantoin, which is renally excreted (Fig. 1) . Defects in purine metabolism can result in tissue accumulation and excessive renal excretion of xanthine, with increased urinary hypoxanthine and decreased uric acid concentrations. Xanthine is moderately insoluble at any urine pH; therefore, high concentration can lead to the formation of xanthine crystals and urolithiasis (Osborne et al. 2010; Jacinto et al. 2013; Raivio et al. 2014) . Xanthinuria is a rare inborn error of metabolism in humans, dogs, and cats. In humans, xanthinuria (Online Mendelian Inheritance in Man 278300) has been well characterized and shown to have an autosomal recessive mode of inheritance with different types (Raivio et al. 2014) , while in animals, little is known about the route of expression.
Xanthinuria in dogs (Online Mendelian Inheritance in Animals 001283-9615) has been reported in Cavalier King Charles spaniels (Van Zuilen et al. 1997; Gow et al. 2011) and Dachshunds (Kucera et al. 1997; Flegel et al. 1998 ). Acquired xanthinuria is also seen in dogs treated with allopurinol, which inhibits the action of the enzyme XDH, and thereby leads to urolithiasis (Ling et al. 1991; Osborne et al. 2010; Torres et al. 2011) .
In cats, xanthinuria (Online Mendelian Inheritance in Animals 001283-9685) has been previously described in five domestic shorthair (DSH) cats (White et al. 1997; Schweighauser et al. 2009; Mestrinho et al. 2013 ) and one Himalayan cat (Tsuchida et al. 2007 ). Laboratories dealing with urolith analysis reported that 0.1-0.3 % of feline calculi were composed of xanthine (Osborne et al. 2004; Cannon et al. 2007; Hesse et al. 2012) . Preliminary molecular genetic studies of one xanthinuric cat found the allelic composition of the XDH gene to be heterozygous with no obvious coding mutation (Tsuchida et al. 2007) .
In this case report, we describe the clinicopathological features of a cat with xanthinuria, crystalluria, urolithiasis, pyuria, bacteriuria, and kidney failure.
Case report
A 2-year-old male neutered DSH cat, weighing 4.25 kg, was presented to a primary care veterinary clinic with a history of intermittent urethral obstruction and red-colored urine of 3-day duration. The cat was housed indoors and was fed a commercial feline dry and canned diet with free access to water. On clinical examination, the cat was alert with good body condition. The caudal abdominal region appeared painful on palpation, and the bladder was of medium size. The cat was sedated, and while passing a catheter through the urethra, resistance to forward movement was encountered. This was suspected to be due to small urethral uroliths or plugs but no such material was retrieved in the collected urine. The catheter was left in situ for 2 days, and anti-inflammatory (carprofen 2 mg/kg body weight), antibiotic (cefovecin 8 mg/kg), and spasmolytic (phenoxybenzamine 0.5 mg/kg) drugs were administered.
The initial urinalysis revealed light yellow, turbid, inadequately concentrated urine (specific gravity (SG) 1.016) with a notable urine sediment which contained many leukocytes, erythrocytes, and crystals as well as few bacteria. The crystals were yellow-brown and appeared amorphous to spheroid or needle shaped (Fig. 2a) . Ammonium urate crystals were initially suspected; however, because of their similar morphological appearance, ammonium urate, amorphous urate, and xanthine crystals cannot be definitively distinguished by light microscopy (Osborne and Stevens 1999; Sink and Weinstein 2012) .
Two days after removing the indwelling catheter, the cat was again presented with urethral obstruction. The cat was anesthetized, and multiple yellow-brown, spherical, gravellike to millet grain-size uroliths were collected from the urethra. A perineal urethrostomy was performed to reduce the risk of further obstruction.
Based upon the quantitative infrared spectroscopic analysis (Harnsteinanalysezentrum Bonn, Germany), the uroliths were pure (100 %) xanthine. Abdominal ultrasound 12 weeks after the first presentation revealed multiple small calculi in both renal pelvises. They were assumed to be xanthine nephroliths but were not removed for further investigation.
Over the next 18 months, following initial presentation, five additional urinalyses were performed on urine collected by catheterization under sedation (weeks 2, 12, 17, 44, and 84). Aside from finding persistently inadequately concentrated urine (urinary SG 1.012-1.018), the urine sediments contained many leukocytes, none to many erythrocytes, variable degrees of bacteriuria, and few to many crystals. The crystals found in the sediment resembled those described in the first urinalysis, and low numbers of rhomboid-shaped crystals, morphologically consistent with uric acid crystals, were also present ( Fig. 2b, c; week 2). Additionally, a few rosette-like yellow-brown crystals, likely being composed of small rhomboid crystals, were also noted ( Fig. 2d; week 12) .
Additionally, Pseudomonas aeruginosa was cultured from the urine at week 12, and treatment with marbofloxacin (2 mg/kg) was initiated based on the results of the urinary antibiogram. Repeat urinary culture at week 17 revealed persistence of Pseudomonas as well as anaerobic bacteria, Bacteroides fragilis, infection. Ciprofloxacin (15 mg/kg) was administered but no follow-up culture of urine was performed. A chronic bacterial urinary tract infection (UTI) secondary to catheterization and surgery was suspected.
During the 18-month follow-up period, blood was examined at weeks 12, 44, and 84. While the results of the hematological analyses were unremarkable, the serum biochemistry revealed persistent to progressive, moderate azotemia and hyperphosphatemia and a mild hypercholesteremia. These results, together with the inadequately concentrated urine, informed a diagnosis of secondary chronic kidney failure (CKF).
In order to confirm the xanthinuria, urinary xanthine and hypoxanthine concentrations were measured by highperformance liquid chromatography (week 70) and serum and urinary uric acid concentrations were measured on weeks 12, 17, 44, 70, and 84 (Tables 1 and 2 ). Xanthine concentration in a spot urine sample were measured and compared to urinary creatinine levels revealing significantly increased levels in the affected cat's urine compared to values from ten healthy control cats in which hypoxanthine and xanthine was not detected (Table 1) . Urinary uric acid/creatinine ratios were surprisingly increased when compared to values from control cats with the value from the last visit being the highest (Tables 1 and 2). In contrast, the affected cat's serum uric acid concentrations remained within the normal range ( Table 2) .
The cat continued to have intermittent stranguria, pollakiuria, bacteriuria, and hematuria which were managed with carprofen (2 mg/kg), after which the clinical signs resolved. The cat was euthanized due to worsening clinical condition at 6 years of age, 4 years after initial diagnosis of xanthinuria. No post-mortem examination was performed.
Discussion
This report describes a young adult castrated DSH cat with xanthinuria similar to five previously described cats (White et al. 1997; Tsuchida et al. 2007; Schweighauser et al. 2009; Mestrinho et al. 2013) . A diagnosis of hereditary xanthinuria was suspected based upon the urinary crystal morphology and confirmed by analyses showing calculi made up of 100 % xanthine together with high urinary xanthine values. However, this cat additional to the xanthinuria also suffered mild uric aciduria and developed secondary bacterial UTI, and a progressive CKF. Xanthine crystals have been described in different shapes including spheroid, amorphous, or ovoid structures with yellow-brown color (Osborne and Stevens 1999; Sink and Weinstein 2012) or rhomboid shape (Althof and Kindler 2006) and can present a diagnostic challenge, as they cannot be distinguished morphologically from ammonium urate or amorphous urate (Osborne and Stevens 1999; Sink and Weinstein 2012) . Particularly, the rhomboid crystals (Fig. 2c, d ) resemble either uric acid (Osborne et al. 1996a) or xanthine (Althof and Kindler 2006) . The crystals seen in this cat also appear similar to those found in dogs treated with allopurinol (Osborne and Stevens 1999) , but the cat had no exposure to that drug. As this cat had both severe xanthinuria and mild uric aciduria, the very polymorphic crystals observed may reflect both metabolites. However, the crystals were not biochemically analyzed and the reason for the mild uric aciduria was not further investigated and thus remains unexplained.
Similar to the cat in this report, all other xanthinuric cats described previously were initially presented for recurrent feline urinary tract disorder (FLUTD) and urinary tract obstruction. On further examination, either crystals or calculi or both were found. Of the cats with confirmed xanthinuria, three cats had xanthine uroliths (Tsuchida et al. 2007; Schweighauser et al. 2009; Mestrinho et al. 2013 ) and one had xanthine crystalluria (Schweighauser et al. 2009 ). In addition, one cat exhibited both uroliths and crystals (White et al. 1997 ) similar to the cat reported here. Although the uroliths were shown to be 100 % xanthine in this cat, urinary xanthine concentrations were not measured and the crystals were thought to be amorphous phosphates. As the cat reported here had not been exposed to allopurinol or other drugs, a hereditary xanthinuria was the most likely diagnosis.
The present case was complicated by persistent pyuria and bacteriuria. Similarly, Escherichia coli was cultured from a xanthine urolith in one other cat (White et al. 1997) ; however, that infection resolved with antibiotic treatment.
There are various potential causes of UTI in cases of hereditary urolithiasis, but it is unlikely that nephroliths lead directly to the UTI as hereditary nephroliths are not traditionally associated with UTI.
Bacterial infections have been reported in cats with crystalluria (7.5 %), urolithiasis (2.2 %), or both (2.9 %) among 134 cats with FLUTD (Eggertsdottir et al. 2007) . Moreover, the prevalence of UTI was found to be higher in cats which have undergone catheterization or perineal urethrostomy (22-53 %; Griffin and Gregory 1992; Osborne et al. 1996b; Bass et al. 2005; Corgozinho et al. 2007 ). It appears likely that the P. aeruginosa and B. fragilis infections in the cat reported here developed secondary to repeated catheterization and perineal urethrostomy and may have ascended to the kidneys and thereby persisted. Metabolically, xanthinuria due to a XDH deficiency is characterized by increased hypoxanthine and xanthine and decreased uric acid concentrations in urine and blood (Osborne et al. 2010; Raivio et al. 2014) . This metabolic crossover pattern has been previously reported in one cat (Schweighauser et al. 2009 ). Similarly, increased hypoxanthine and xanthine concentrations in blood and urine were noted in another affected cat, but uric acid concentrations were not measured (Mestrinho et al. 2013) . The previously reported xanthinuric Himalayan cat (Tsuchida et al. 2007 ) had increased serum and urinary xanthine concentrations but normal serum hypoxanthine levels (urine hypoxanthine was not measured). Moreover, the case reported by Tsuchida had a urinary uric acid/creatinine ratio which was at the upper limit of normal, showing a similar metabolic pattern to the findings in the present case. Interestingly, xanthine uroliths have been reported to contain uric acid in a few other cats (Osborne et al. 2004) . It is likely that these cats carried a different metabolic defect than XDH deficiency or that the purine metabolism in cats is different from other studied mammals.
Azotemia was present at the first serum evaluation (week 12) and persisted during the follow-up period leading to a diagnosis of CKF. Renal failure related to xanthine urolithiasis has been reported in humans (Bradbury et al. 1995; Sikora et al. 2006; Fujiwara et al. 2012 ) and dogs (Kucera et al. 1997; Van Zuilen et al. 1997; Flegel et al. 1998; Gow et al. 2011 ) and in one xanthinuric cat (Schweighauser et al. 2009 ). The cat reported by Mestrinho et al. (2013) had bilateral ureteral obstruction with xanthine uroliths and was markedly azotemic at presentation, but after removing the blockage, no renal failure was noted. The cause of CRF in the case reported here may have been due to urinary obstruction and persistent UTI. It should be noted that no association has been reported between different nephrolithiasis and progression of chronic kidney disease or death in cats (Ross et al. 2007 ).
The recommended management for xanthinuria involves feeding low-protein or low-purine diet in order to reduce purine excretion (Tsuchida et al. 2007; Osborne et al. 2010; Gow et al. 2011; Mestrinho et al. 2013) , but the effectiveness of this dietary management is not established in cats.
The current case report describes a cat with hereditary xanthinuria, xanthine uroliths, crystals, pyuria, bacteriuria, and renal failure. The crystals, uroliths, catheterizations, and perineal urethrostomy may have led to recurrent UTI and thereby decreased the cat's quality of life. Measuring xanthine concentration in urine is indicated in cases of suspected ammonium urate or amorphous urate or xanthine crystalluria. The presence of uric aciduria may indicate a different metabolic defect than XDH or one of a range of different metabolic patterns in cats.
